Published in Clin Exp Immunol on July 01, 1979
Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med (1977) 9.57
Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35
Lymphocyte migration and immune responses. Prog Allergy (1975) 3.21
The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med (1972) 2.66
Specific unresponsiveness of recirculating lymphocytes ater exposure to histocompatibility antigen in F 1 hybrid rats. Nat New Biol (1971) 2.50
Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells. Cell Immunol (1972) 1.78
Effect of recent antigen priming on adoptive immune responses. I. Specific unresponsiveness of cells from lymphoid organs of mice primed with heterologous erythrocytes. J Exp Med (1973) 1.58
The active E rosette test: correlation with delayed cutaneous hypersensitivity. J Immunol (1976) 1.36
Effect of recent antigen priming on adoptive immune responses. III. Antigen-induced selective recruitment of subsets of recirculating lymphocytes reactive to H-2 determinants. J Exp Med (1976) 1.30
An in vitro model of lymphocyte homing. II. Membrane and cytoplasmic events involved in lymphocyte adherence to specialized high-endothelial venules of lymph nodes. J Immunol (1977) 1.23
Hypersensitivity to tetanus toxoid. J Allergy Clin Immunol (1973) 1.22
Identification of T and B cells in mouse and man. Lancet (1972) 1.16
Effect of recent antigen priming on adoptive immune responses. II. Specific unresponsiveness of circulating lymphocytes from mice primed with heterologous erythrocytes. J Exp Med (1974) 1.08
Effect of recent antigen priming on adoptive immune responses. IV. Antigen-induced selective recruitment of recirculating lymphocytes to the spleen demonstrable with a microculture system. J Exp Med (1976) 1.05
Delineation and quantitation of human peripheral blood lymphocyte subpopulations by electrophoretic mobility and role of surface charge in cell to cell interaction. J Immunol (1977) 0.97
Inverse relationship between net electric charge on the antigen and that on the sensitized cell in cellular immune response: demonstration with basic encephalitogen of the brain. J Exp Med (1975) 0.88
Lack of inverse relationship between the net charge of T-independent immunogens and the responding spleen cells. J Immunol (1975) 0.85
Changes in the electrophoretic mobility of mouse lymph node lymphocytes during ontogeny. Immunology (1977) 0.84
Studies of tetanus toxoid-induced blast transformation of lymphocytes of immunized healthy donors. Clin Immunol Immunopathol (1977) 0.84
Isolation and electrophoretic mobility of three lymphoid populations in normal human blood. Eur J Cancer (1977) 0.81
Migratory behavior of lymphocytes with specific reactivity to alloantigens. I. Selective recruitment to spleen, bone marrow, and liver after an intravenous challenge. J Immunol (1977) 0.81
Specific alteration of the surface charge of immunocytes. Nat New Biol (1972) 0.80
Application of cell electrophoretic methods (preparative and analytical) in demonstrating the surface heterogeneity of T-lymphocytes in man. Biomedicine (1978) 0.79
Electrophoretic mobility of lymphocytes in new born. Biomedicine (1976) 0.79
The effect of antigen given intravenously on specific antigen-sensitive lymphocytes of peripheral blood in man. Clin Exp Immunol (1970) 0.78
Differences in mitogen response and electrophoretic mobility of two T-lymphocyte sub-populations. Eur J Cancer (1977) 0.77
Inhibition of mixed lymphocyte reactions in humans after immunization with tetanus toxoid. Transplantation (1977) 0.77
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
GATE: a simulation toolkit for PET and SPECT. Phys Med Biol (2004) 7.88
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol (2000) 5.20
Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest (1972) 3.13
Nucleotide sequence of the gene for heat-stable enterotoxin II of Escherichia coli. Infect Immun (1983) 2.13
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication. Aliment Pharmacol Ther (2013) 2.00
Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol (1994) 2.00
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol (1986) 1.98
The immunological responses observed in field studies in Africa with group A meningococcal vaccines. Prog Immunobiol Stand (1971) 1.96
Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst (1994) 1.92
Low grade supratentorial astrocytomas. Management and prognostic factors. Cancer (1994) 1.86
Clinical relevance of immunohistochemical detection of multidrug resistance P-glycoprotein in breast carcinoma. J Natl Cancer Inst (1991) 1.82
Long-term efficacy of gamma knife radiosurgery in mesial temporal lobe epilepsy. Neurology (2008) 1.64
[Vaccination against measles by live vaccines. 2 experiments in tropical Africa (Senegal)]. Presse Med (1965) 1.59
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol (1993) 1.58
Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med (1999) 1.55
Specific and nonspecific immune responses to fasting and refeeding differ in healthy young adult and elderly persons. Am J Clin Nutr (2001) 1.54
Early and delayed MR and PET changes after selective temporomesial radiosurgery in mesial temporal lobe epilepsy. AJNR Am J Neuroradiol (1999) 1.49
Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. J Antimicrob Chemother (1989) 1.48
High-level secretion of human growth hormone by Escherichia coli. Gene (1987) 1.47
Gastrointestinal stromal tumors. Abdom Imaging (2006) 1.46
Systematic review: Proton pump inhibitor-associated acute interstitial nephritis. Aliment Pharmacol Ther (2007) 1.45
Prognostic value of initial tumor parameters after metastatic relapse. Cancer Invest (2011) 1.45
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer. J Clin Oncol (2002) 1.44
Nature and nurture in childhood weight. Pediatrics (1977) 1.39
Generation of antibody activity from immunoglobulin polypeptide chains produced in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.36
Involvement of phosphatidylinositol 3-kinase in stromal cell-derived factor-1 alpha-induced lymphocyte polarization and chemotaxis. J Immunol (1999) 1.34
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol (2005) 1.33
Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci (1994) 1.31
Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology (1997) 1.30
Effects of intracoronary streptokinase and intracoronary nitroglycerin infusion on coronary angiographic patterns and mortality in patients with acute myocardial infarction. N Engl J Med (1984) 1.25
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25
Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J Med Virol (2009) 1.19
Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. N Engl J Med (1988) 1.18
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol (1997) 1.12
Methionine dependency and cancer treatment. Cancer Treat Rev (2003) 1.11
Surgical treatment of a rare congenital anomaly of the vertebral artery: case report and review of the literature. Neurosurgery (1991) 1.10
Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer (1993) 1.10
Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol (1995) 1.10
In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum Gene Ther (1999) 1.09
HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases. Breast (2005) 1.09
[Cerebral malaria: electroencephalographic, neuropathologic aspects, physiopathologic problems]. Pathol Biol (Paris) (1969) 1.09
A continuous series of 96 laparoscopic inguinal hernia repairs in children by a new technique. Surg Endosc (2004) 1.09
Agglutination of peripheral blood lymphocytes from cancer patients and not from healthy controls, with the F2A1 histone fraction. Br J Cancer (1975) 1.08
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer. J Clin Oncol (1992) 1.08
Comparison of mortality risk: a score for very low birthweight infants. Arch Dis Child Fetal Neonatal Ed (1997) 1.07
Chloroquine-resistant falciparum malaria in Benin. Lancet (1986) 1.06
Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry (2001) 1.05
Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer (1992) 1.04
Dihydropyrimidine dehydrogenase activity in cancer patients. Eur J Cancer (1993) 1.03
Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in culture. Cornea (1997) 1.02
Hereditary complement factor I deficiency. QJM (1994) 1.02
[Epidemiologic aspects of purulent meningitis in tropical Africa (1052 cases observed in Dakar)]. Lyon Med (1972) 1.00
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer. Eur J Cancer (1997) 1.00
Effect of tunicamycin on transport of lysosomal enzymes in cultured skin fibroblasts. Eur J Biochem (1979) 0.99
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes. Ann Oncol (2008) 0.98
On the existence of stationary states during granular compaction. Eur Phys J E Soft Matter (2007) 0.97
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993). Eur J Cancer (2006) 0.96
An antifungal exo-alpha-1,3-glucanase (AGN13.1) from the biocontrol fungus Trichoderma harzianum. Appl Environ Microbiol (2001) 0.96
Lenograstim prevents morbidity from intensive induction chemotherapy in the treatment of inflammatory breast cancer. J Clin Oncol (1995) 0.95
Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience. Eur J Cancer (1999) 0.95
[Vaccination against measles in a rural Senegalese environment with superattenuated live vaccine (Schwarz) by means of an injector without a needle (Dermojet). Possibilities of combination with vaccine]. Bull Soc Med Afr Noire Lang Fr (1965) 0.95
Rho and Rho-associated kinase modulate the tyrosine kinase PYK2 in T-cells through regulation of the activity of the integrin LFA-1. J Biol Chem (2001) 0.95
Neoadjuvant endocrine therapy in breast cancer. Breast (2005) 0.94
Poisson goodness of fit and the non-randomness of daily mortality. J Epidemiol Community Health (1979) 0.94
Molecular detection of a late-appearing BCR-ABL gene in a child with T-cell acute lymphoblastic leukemia. Ann Hematol (1998) 0.94
[Antitetanus vaccination: preliminary results of a study in Africa]. Dev Biol Stand (1978) 0.94
Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol (1991) 0.92
Primary chemotherapy in breast cancer: correlation between tumor response and patient outcome. Am J Clin Oncol (1998) 0.91
Gamma knife surgery for mesial temporal lobe epilepsy. Epilepsia (1999) 0.91
O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation. Int J Cancer (1999) 0.91
Detection of Epstein-Barr viral genomes in lymph nodes of Hodgkin's disease patients. Mol Carcinog (1990) 0.90
Laparoscopic liver sectionectomy 2 and 3 (LLS 2 and 3): towards the "gold standard". J Hepatobiliary Pancreat Surg (2009) 0.90
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancers. Eur J Cancer (2005) 0.90
End-tidal CO2 analysis in sleep apnea syndrome. Conditions for use. Chest (1993) 0.90
Phase II study of sequential administration of docetaxel followed by doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer. J Clin Oncol (2001) 0.89
[Esophageal achalasia, sleep disorders and chorea in a tauopathy without ophthalmoplegia, parkinsonian syndrome, nor dementia (progressive supranuclear palsy?): clinicopathological study]. Rev Neurol (Paris) (2008) 0.89
Familial correlations of longevity: an isolate-based study. Am J Med Genet (1978) 0.89
[Proteinuria, proteinaemia, and serum transaminase activity in 23 confirmed cases of yellow fever]. Bull World Health Organ (1970) 0.89
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiforme. Ann Oncol (2003) 0.89
Complete response of a gastric primary after a short but toxic course of 'S-1' EORTC Early Clinical Studies Group. Ann Oncol (1999) 0.89
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients. Ann Oncol (2002) 0.88
Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate. Br J Cancer (2003) 0.88
Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med (1998) 0.88
Radiosurgery for trigeminal neuralgia and epilepsy. Neurosurg Clin N Am (1999) 0.88
[Paludism in the Dakar metropolitan area (from hospital experience)]. Bull Soc Med Afr Noire Lang Fr (1968) 0.88
[Cross serological reactions between Plasmodium falciparum and Plasmodium cynomolgi Bastianellii. Application to the serodiagnosis, by immunofluorescence, of human Plasmodium falciparum malaria]. Bull Soc Pathol Exot Filiales (1967) 0.88
High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients. Infection (1987) 0.88
Effect of sleep apnea syndrome on the circadian profile of cortisol in obese men. Am J Physiol Endocrinol Metab (2007) 0.88
Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria. J Nucl Cardiol (1998) 0.88
ThPTR2, a di/tri-peptide transporter gene from Trichoderma harzianum. Fungal Genet Biol (2006) 0.87
Subcellular localization of BRCA1 protein in sporadic breast carcinoma with or without allelic loss of BRCA1 gene. Int J Oncol (1999) 0.87
Adherence with oral oncologic treatment in cancer patients: interest of an adherence score of all dosing errors. Oncology (2012) 0.87